Skip to main content

Pharvaris N.V.

PHVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001830487

In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 20 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q3 2024

Institutional positions in Pharvaris N.V. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
+16 vs. Q2 2024
Shares held
45.0M
+2.04M (+4.7%) vs. Q2 2024
Total value
$834.2M
+$25.7M (+3.2%) vs. Q2 2024
New holders
19
13 more added
Sold out
3
6 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PHVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 51 institutions
Q1 2021: 33 institutionsQ2 2021: 28 institutionsQ3 2021: 25 institutionsQ4 2021: 22 institutionsQ1 2022: 22 institutionsQ2 2022: 20 institutionsQ3 2022: 21 institutionsQ4 2022: 25 institutionsQ1 2023: 21 institutionsQ2 2023: 21 institutionsQ3 2023: 21 institutionsQ4 2023: 36 institutionsQ1 2024: 35 institutionsQ2 2024: 36 institutionsQ3 2024: 51 institutionsQ4 2024: 54 institutionsQ1 2025: 52 institutionsQ2 2025: 60 institutionsQ3 2025: 83 institutionsQ4 2025: 106 institutionsQ1 2026: 110 institutionsQ2 2026: 125 institutions
Value heldQ3 2024: $834.2M
Q1 2021: $616.5MQ2 2021: $406.3MQ3 2021: $380.3MQ4 2021: $321.1MQ1 2022: $397.1MQ2 2022: $494.0MQ3 2022: $173.6MQ4 2022: $239.6MQ1 2023: $173.9MQ2 2023: $441.6MQ3 2023: $606.6MQ4 2023: $1.14BQ1 2024: $980.5MQ2 2024: $808.6MQ3 2024: $834.2MQ4 2024: $855.8MQ1 2025: $705.5MQ2 2025: $792.7MQ3 2025: $1.44BQ4 2025: $1.64BQ1 2026: $1.67BQ2 2026: $2.23B
Institutions holding PHVS and their total value by quarter
QuarterHoldersValue
Q2 2026125$2.23B
Q1 2026110$1.67B
Q4 2025106$1.64B
Q3 202583$1.44B
Q2 202560$792.7M
Q1 202552$705.5M
Q4 202454$855.8M
Q3 202451$834.2M
Q2 202436$808.6M
Q1 202435$980.5M
Q4 202336$1.14B
Q3 202321$606.6M
Q2 202321$441.6M
Q1 202321$173.9M
Q4 202225$239.6M
Q3 202221$173.6M
Q2 202220$494.0M
Q1 202222$397.1M
Q4 202122$321.1M
Q3 202125$380.3M
Q2 202128$406.3M
Q1 202133$616.5M

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Pharvaris N.V.; share changes are against Q2 2024.

Institutions holding PHVS in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Bank of America Corp15$2780.00%−6,106−99.8%Reduced
Amundi84$1.50K0.00%+84New
JPMorgan Chase & Co253$4.69K0.00%+253New
Wells Fargo & Company800$14.8K0.00%+100+14.3%Added
UBS Group AG1,591$29.5K0.00%+1,424+852.7%Added
ADAR1 Capital Management, LLC2,000$37.0K0.01%00.0%Unchanged
Public Employees Retirement System of Ohio3,100$57.4K0.00%+3,100New
Virtus ETF Advisers LLC5,089$94.2K0.04%+88+1.8%Added
Barclays PLC5,700$105.6K0.00%+5,700New
Legal & General Group Plc8,861$164.1K0.00%+8,861New
Ghisallo Capital Management LLC11,249$208.3K0.01%+11,249New
Vanguard Group Inc12,740$235.9K0.00%+12,740New
California State Teachers Retirement System12,950$239.8K0.00%+12,950New
Northern Trust Corp15,744$291.6K0.00%+15,744New
Crestline Management, LP15,819$293.0K0.02%+15,819New
Deutsche Bank AG16,081$297.8K0.00%+16,081New
HighVista Strategies LLC22,768$421.7K0.15%+6,018+35.9%Added
Morgan Stanley24,251$449.1K0.00%+955+4.1%Added
Millennium Management LLC24,307$450.2K0.00%−14,638−37.6%Reduced
Swiss National Bank26,257$486.3K0.00%+26,257New
Jane Street Group, LLC28,418$526.3K0.00%+28,418New
HealthInvest Partners AB34,328$635.8K0.30%00.0%Unchanged
TD Asset Management Inc36,216$671.4K0.00%−49,600−57.8%Reduced
Geode Capital Management, LLC36,977$684.8K0.00%+5,753+18.4%Added
Alps Advisors Inc42,308$783.5K0.01%+42,308New
Manufacturers Life Insurance Company, The44,878$831.1K0.00%−10,200−18.5%Reduced
UBS Asset Management Americas Inc48,896$905.6K0.00%+48,896New
State Street Corp53,980$999.7K0.00%+53,980New
Marshall Wace, LLP59,014$1.09M0.00%+7,846+15.3%Added
Goldman Sachs Group Inc63,830$1.18M0.00%+2,360+3.8%Added
BlackRock, Inc.195,348$3.62M0.00%+195,348New
Patient Square Capital LP242,341$4.49M1.67%+242,341New
Price T Rowe Associates Inc325,488$6.03M0.00%−259,783−44.4%Reduced
Sphera Funds Management Ltd.439,292$8.14M1.33%+36,027+8.9%Added
Soleus Capital Management, L.P.598,169$11.1M0.92%+198,739+49.8%Added
Sofinnova Investments, Inc.600,302$11.1M0.92%−1,232−0.2%Reduced
Octagon Capital Advisors LP620,470$11.5M1.84%+620,470New
Rock Springs Capital Management LP756,931$14.0M0.46%00.0%Unchanged
5AM Venture Management, LLC797,600$14.8M3.05%00.0%Unchanged
EcoR1 Capital, LLC900,000$16.7M0.57%00.0%Unchanged
Cormorant Asset Management, LP1,466,460$27.2M1.44%00.0%Unchanged
Novo Holdings A/S1,725,000$31.9M1.59%00.0%Unchanged
Commodore Capital LP1,911,433$35.4M2.21%+101,258+5.6%Added
Deerfield Management Company, L.P. (Series C)2,031,700$37.6M0.56%+634,421+45.4%Added
Bain Capital Life Sciences Investors, LLC3,303,381$61.2M6.36%00.0%Unchanged
VR Adviser, LLC3,395,606$62.9M3.29%00.0%Unchanged
Viking Global Investors LPSuperinvestorViking Global Investors3,653,310$67.7M0.25%00.0%Unchanged
venBio Partners LLC4,289,304$79.4M40.88%00.0%Unchanged
Foresite Capital Management IV, LLC4,397,881$81.4M53.23%+104,027+2.4%Added
FMR LLC5,205,656$96.4M0.01%00.0%Unchanged
General Atlantic LLC7,531,252$139.5M3.97%00.0%Unchanged
Walleye Capital LLC0$00.00%−48,768−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−15,883−100.0%Sold out
Citadel Advisors LLC0$00.00%−14,472−100.0%Sold out
BlackRock Inc.––––Not filed